The survival analysis indicated that high expression of both ClC-3 and SGK1 was associated with poor survival rate in STAD patients, suggesting that ClC-3 and SGK1 might be tumor-promoting factors in STAD development. This evidence concerns the gene CLCN3 and gastric adenocarcinoma.